NEO-920

Our research focuses on the development of new drugs for the treatment of colon cancer, metabolic and neurodegenerative diseases.

VIEW FEATURES

NEO-920

Therapeutic area

Oncology

Target disease

Colon cancer

Study phase

Preclinical: In vitro

100%

Preclinical: In vivo

100%

Clinic I

Not initiated

Clinic II

Not initiated

Clinic III

Not initiated

International Application No.

PCT/ES2021/070738

Scientific publication

Colon cancer therapy with calcium phosphate nanoparticles loading bioactive compounds from Euphorbia lathyris: In vitro and in vivo assay

Discover the Future

We are a biotechnology company committed to the discovery of efficient and effective bioactive principles as pharmaceuticals, nutraceuticals or useful in the field of plant biology.